Estimating progression to cirrhosis in chronic hepatitis C virus infection.
about
Adiponectin serum level in chronic hepatitis C infection and therapeutic profileManagement of endocrine disease: Secondary osteoporosis: pathophysiology and managementQuantification of hepatitis C virus in human liver and serum samples by using LightCycler reverse transcriptase PCR.Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionDifferential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic CellsConserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goatsOccult persistence and lymphotropism of hepatitis C virus infectionMolecular mechanisms of insulin resistance in chronic hepatitis CEffective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus InfectionHepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional studyBest strategies for global HCV eradication.The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in ChinaEpidemiology of viral hepatitis and hepatocellular carcinomaNatural history of chronic hepatitis CGlobal epidemiology and burden of HCV infection and HCV-related disease.Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.Accelerated failure time models for censored survival data under referral bias.Patients' preferences for treatment of hepatitis CDNA methylation: potential biomarker in Hepatocellular Carcinoma.The hepatitis C cascade of care: identifying priorities to improve clinical outcomesThe cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients.Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UKEffect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patientsLiver disease, HIV and aging.Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysisModelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.Liver transplantation for alcoholic liver disease.Historical trends and projected hospital admissions for chronic hepatitis C infection in Canada: a birth cohort analysis.Direct-acting antiviral agents for hepatitis C virus infection.Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)Long-term effects of antiviral therapy in patients with chronic hepatitis C.Preserved MHC-II antigen processing and presentation function in chronic HCV infection.Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study.Hepatocellular carcinoma and hepatitis C in the United States.Is severe liver disease a common outcome for people with chronic hepatitis C?Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programsFibrosis and disease progression in hepatitis C.Prevention and treatment of hepatitis C in injection drug users.Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence.
P2860
Q26827639-F18789F2-783C-4886-B693-803D0157AAADQ26998249-8D5FEAC5-595D-4DD3-965F-BDCD1D9E5668Q27473054-B7E2B054-B680-4852-A885-040789EA704EQ27485372-C002E72A-C11F-4BCF-9997-EAAD44905CA0Q27488392-65FB8E21-6380-4E36-B433-3821B49BBD16Q27488724-F98A1144-F1F2-4417-943F-EC8F2277B471Q27488897-498F5B39-0646-4CBF-8303-A163A69B92EBQ27489665-0F2810DA-0779-4BF5-997E-2D48C51F9C25Q27490862-284272F6-03CC-49B6-8932-43FAB4E17028Q27491345-CE4BD291-0802-4D90-A89A-6AB820E2D7BCQ27693824-E5E00CA7-613D-45BB-8689-76DB5EB586DCQ28550281-B2786DEF-EE0C-4F46-8634-969E0BF6F752Q29617918-CF784BD3-817F-4667-A558-D4564AC04667Q29620673-221867BA-244B-4E32-AE16-FDF23A8275AEQ30240220-E19AEFEF-138C-41D8-969B-09D81C47E7C6Q30429470-AB16CAEF-0B75-4A2A-BCCE-473B3A1D120FQ30577871-DEA3745A-4AC4-4C2C-97DF-11F09B8D39B8Q33615461-98CF5CC2-653B-432D-8E44-CFEA979876D5Q33617129-C32FAA5A-7DBD-42CF-A0EB-F1EE3A162660Q33632459-86EA90C5-BB27-4A5B-B6D9-C0CD598F7421Q33710740-82A049E9-DB18-4057-A2F7-0C7A72F4CB6EQ33795154-21D48BD2-C1C5-4F1C-9ABC-A7CAF9F837CBQ33796039-FEEE88C4-9854-4F7F-9255-B922E115154CQ33810577-DCD1FEF0-E8F6-4C3C-A4EF-E5B694C4A1EBQ33921088-422E0F1B-6631-4807-9501-E615DC8718B7Q34028307-2A16F4CB-64C8-4B1C-BDA1-9A4652EA5CBFQ34134927-2DAA3954-A601-4B26-B9B8-7E872216A027Q34280145-20562888-ECD8-46C8-A130-27C9BC6C6F5EQ34321440-CE73A0C6-8A45-4E4E-A0BA-6DBEDCC32D6EQ34350873-AF75883E-1EC0-4BEF-A0AB-375ACFC31146Q34415157-9D491877-261E-42C5-A4DB-CF7ABB1F1807Q34423936-A075E5D8-5A41-42DC-A74F-AC51EE9BD0ACQ34491134-A0CBE76E-027D-4F1A-8AF8-84C9E4C4EB45Q34528514-0EC76D27-0375-485E-A708-3923F08507BBQ34619377-E524FBFA-E745-4C6A-A0EE-27174BE20F07Q34717544-A7D43DA0-C061-4E07-9A68-7A618ED486B5Q34735072-A14A62E9-93C3-4085-AEB0-50FDB3873CDAQ34984040-5AF60618-F3AB-4F4F-9C4A-CF60C328A5D8Q34984130-63B6E59E-E7DA-4AF6-A123-86EA666480E5Q35058571-638E4A0B-C3AE-42B7-A92E-43C2D22E3983
P2860
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
@ast
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
@en
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
@nl
type
label
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
@ast
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
@en
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
@nl
prefLabel
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
@ast
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
@en
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
@nl
P2093
P356
P1433
P1476
Estimating progression to cirrhosis in chronic hepatitis C virus infection
@en
P2093
Freeman AJ
Von Overbeck J
P304
P356
10.1053/JHEP.2001.27831
P407
P433
P577
2001-10-01T00:00:00Z